Metreleptin

ATC A16AA07 · 6 markets · 14 records

Metreleptin 6 markets · 14 records Forms

GB 3 records · 3 strengths

11.3 mginjectionMyalepta 3mg powder for solution for injection vials also in ES·FR
5.8 mginjectionMyalepta 3mg powder for solution for injection vials also in ES·FR
3 mginjectionMyalepta 3mg powder for solution for injection vials also in ES·FR

CA 3 records · 3 strengths

11.3 mgpowderMYALEPTA
5.8 mgpowderMYALEPTA
3 mgpowderMYALEPTA

ES 3 records · 3 strengths

11.3 mginjectionMYALEPTA also in GB·FR
5.8 mginjectionMYALEPTA also in GB·FR
3 mginjectionMYALEPTA also in GB·FR

FR 3 records · 3 strengths

11.3 mginjectionMYALEPTA 11,3 mg, poudre pour solution injectable also in GB·ES
5.8 mginjectionMYALEPTA 11,3 mg, poudre pour solution injectable also in GB·ES
3 mginjectionMYALEPTA 11,3 mg, poudre pour solution injectable also in GB·ES

US 1 records · 1 strengths

11.3 mg/2.2 mLinjectionMyalept

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名MYALEPTA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.